The application was submitted on December 20, 2023. Assuming a typical validation and review start in January, the process has now run just over seven months. This is in line with historical timelines for Advanced Therapy Medicinal Products. Even if we assume minor delays for RFIs, we are still inside the expected window.
Market Data 
Markets 
